Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mladen Solarić"'
Publikováno v:
Therapeutic Advances in Urology, Vol 10 (2018)
Background: Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonists is well established for the treatment of men with metastatic prostate cancer. As clear differences in efficacy, safety, or tolerability between
Externí odkaz:
https://doaj.org/article/a0b0fdfdce564c538007b71111893ffa
Publikováno v:
Therapeutic Advances in Urology, Vol 9 (2017)
Background: There are two slow-release ready-to-use forms of leuprorelin acetate (1-month and 3-month) that are available as solid, biodegradable implants for the treatment of advanced, hormone-sensitive prostate cancer. These implants have been show
Externí odkaz:
https://doaj.org/article/bee2797cba3f43b099ef599cdae09349
Autor:
Zvonimir Curić, Tomislav Sorić, Igor Tomašković, Tihana Boraska Jelavić, Kristijan Krpina, Željko Kaštelan, Tomislav Kuliš, Dražen Huić, Vesna Bišof, Ana Marija Alduk, Dag Zahirović, Marija Gamulin, Mladen Solarić, Stela Bulimbašić, Katarina Vilović, Tomislav Omrčen, Ante Punda, Blanka Jakšić, Ana Fröbe
Publikováno v:
Liječnički vjesnik. 141
Publikováno v:
Therapeutic Advances in Urology, Vol 10 (2018)
Background: Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonists is well established for the treatment of men with metastatic prostate cancer. As clear differences in efficacy, safety, or tolerability between
Publikováno v:
Therapeutic Advances in Urology, Vol 9 (2017)
Background: There are two slow-release ready-to-use forms of leuprorelin acetate (1-month and 3-month) that are available as solid, biodegradable implants for the treatment of advanced, hormone-sensitive prostate cancer. These implants have been show
Autor:
Marija, Gamulin, Ira Pavlović, Ruzić, Mislav, Grgić, Marijana, Jazvić, Mladen, Solarić, Dag, Zahirović, Robert, Zorica, Tomislav, Omrcen, Marija, Petković, Mate, Matić, Zeljko, Fuckar, Boris, Ruzić, Josip, Pasini, Marijan, Situm, Gordana, Dordević, Damir, Miletić, Tade, Tadić, Zeljko, Kastelan, Davor, Librenjak, Ivan, Gilja, Katarina, Vilović, Bozo, Kruslin, Hrvoje, Kuvezdić
Publikováno v:
Lijecnicki vjesnik. 135(11-12)
Urothelial cancer is the most common bladder cancer. Hematuria is the most common presenting symptom in patients with bladder cancer. The most common diagnostics of bladder cancer is performed by transurethral resection of bladder after which pathohi
Autor:
Mladen, Solarić, Mislav, Grgić, Tomislav, Omrcen, Marija, Petković, Ana, Fröbe, Nenad, Belaj, Robert, Zorica, Bozo, Kruslin, Gordana, Dordević, Zeljko, Kastelan, Boris, Ruzić, Ivan, Gilja, Ivan, Krolo, Katarina, Vilović, Davor, Librenjak, Eduard, Vrdoljak, Marijan, Situm, Ranka Stern, Padovan, Zeljko, Vojnović
Publikováno v:
Lijecnicki vjesnik. 135(11-12)
Prostate adenocarcinoma is the second most common solid neoplasm in male population in Croatia. It rarely causes symptoms unless it is advanced. The finding of PSA rise is the most common reason for diagnostic workout. Treatment plan is based on TNM
Autor:
Mislav Grgić, Ante Bolanča, Dubravka Ledina, Damir Gugić, Mladen Solarić, Tomislav Omrčen, Robert Zorica, Josip Galić, Davor Trnski, Josip Pasini, Ranka Štern Padovan, Marija Petković, Antonija Balenović, Antonio Juretić, Željko Kaštelan, Marija Gamulin
Publikováno v:
Liječnički vjesnik
Volume 135
Issue 11-12
Volume 135
Issue 11-12
Tumori testisa najčešći su solidni tumori u muškaraca u dobi od 15. do 34. godine. Njihova je incidencija u svijetu podvostručena u posljednjih 40 godina. Tumori zametnih stanica obuhvaćaju 95% svih tumora testisa, a podijeljeni su u dva osnovn
Publikováno v:
Liječnički vjesnik
Volume 135
Issue 1-2
Volume 135
Issue 1-2
Značajan napredak u ranom otkrivanju i kvalitetnije liječenje oboljelih rezultirali su činjenicom da u najrazvijenijim zemljama gotovo 90% žena s dijagnozom raka dojke preživi duže od 5 godina nakon dijagnoze i liječenja. Kod jedne od dvadeset
Autor:
Marija Gamulin, Ira Pavlović Ružić, Mislav Grgić, Marijana Jazvić, Mladen Solarić, Dag Zahirović, Robert Zorica, Tomislav Omrčen, Marija Petković, Mate Matić, Željko Fučkar, Boris Ružić, Josip Pasini, Marijan Šitum, Gordana Đorđević, Damir Miletić, Tade Tadić, Željko Kaštelan, Davor Librenjak, Ivan Gilja, Katarina Vilović, Božo Krušlin, Hrvoje Kuveždić
Publikováno v:
Liječnički vjesnik
Volume 135
Issue 11-12
Volume 135
Issue 11-12
Urotelni rak najčešći je rak mokraćnog mjehura. Hematurija je najčešći simptom pri prezentaciji bolesti. Dijagnoza raka mokraćnog mjehura postavlja se uglavnom transuretralnom resekcijom nakon čega slijedi patohistološka dijagnoza. Nužno j